Q&A: Joe Proto, CEO, Transactis – On Overcoming Early Adversity
While the consequential decisions leading up to the economic crisis of the late 2000s and early 2010s were made well before September 29, 2008, the…
Posted by
While the consequential decisions leading up to the economic crisis of the late 2000s and early 2010s were made well before September 29, 2008, the…
Posted by
The municipal bond market is a thicket of data that can be outdated and doesn’t conform to a standard format, leaving investment firms to spend…
Posted by
The need to innovate and improve the healthcare system is greater than ever before, creating a number of opportunities and challenges for entrepreneurs in healthcare…
Posted by
After 11 years at Progressive Insurance, Steve McKay knew insurance inside and out, including many of the industry’s shortfalls. Steve realized that there were significant…
Posted by
Good Start Genetics is setting the pace for carrier screening. Based on proprietary gene-sequencing technology, Good Start Genetics’ pre-pregnancy test is more accurate and comprehensive,…
Posted by
Our Q&A series turns now to one of our newest partner companies, Spongecell, and its CEO and Co-founder Ben Kartzman. Spongecell is a digital advertising…
Posted by
For the next installment of our partner company Q&A series, we turn to the life sciences side of our portfolio and interviewed Jean Hoffman, Founder,…
Posted by
This year, we launched a Q&A Series with our partner company CEOs to provide insight, lessons learned and first-hand knowledge about what it takes to…
Posted by
Welcome to the inaugural blog post for Safeguard Scientifics’ Q&A Series, featuring our partner company CEOs! We believe that our blog is a perfect medium…
Posted by